Cytomegalovirus Immune Globulin Intravenous (CMV-IGIV) from China
CMV-IGIV is a purified immunoglobulin fraction from human plasma of donors with high CMV antibody titers, used prophylactically in transplant patients. It is classified under HTS 3002.12.00 as other blood fractions for therapeutic use. The product prevents CMV infection through passive antibody transfer.
Duty Rate — China → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Ensure compliance with 21 CFR 640.100 for immune globulin imports
• Document pathogen reduction steps to satisfy biosecurity import checks
• Use tamper-evident packaging to prevent tampering claims at inspection